c‐met mRNA overexpression in human hepatocellular carcinoma

This study was aimed at assessing the presence of c‐met overexpression in human hepatocellular carcinoma and at determining whether this feature is associated with a definite clinical or pathological characteristic. Expression of c‐met was determined by Northern‐blot hybridization of a specific probe (human met proto‐oncogene) in 18 tumoral and nontumoral liver samples obtained in 18 cirrhotic patients with hepatocellular carcinoma submitted to surgical treatment. Eight of the 18 hepatocellular carcinomas exhibited c‐met overexpression, with an increase ranging between 2‐fold and 10‐fold when compared by densi‐tometry with the surrounding liver. By contrast, in the remaining 10 cases c‐met expression was almost identical to that of the surrounding nontumoral liver tissue. Overexpression of c‐met was not related to either the age, sex, etiology or functional status of the underlying liver disease, or to the size of the tumor, to its differentiation degree or to the presence of pseudocapsule invasion and existence of additional neoplastic nodules. These data indicate that almost half of the human hepatocellular carcinomas exhibit c‐met overexpression. Nevertheless, the biological relevance of this characteristic is not known. (Hepatology 1994;19:88‐91).

[1]  S. Hayashi,et al.  Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. , 1992, Gastroenterology.

[2]  D. Labrecque.  Hepatocyte growth factor--how do I know thee? Let me count the ways. , 1992, Gastroenterology.

[3]  T. Nakamura,et al.  Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor , 1992, Molecular and cellular biology.

[4]  K. Matsumoto,et al.  Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. V. Vande Woude,et al.  Expression of c‐met proto‐oncogene in COS cells induces the signal transducing high‐affinity receptor for hepatocyte growth factor , 1992, FEBS letters.

[6]  G. Michalopoulos,et al.  Hepatocyte growth factor , 1992, Hepatology.

[7]  T. Nakamura,et al.  Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[9]  Toshikazu Nakamura,et al.  Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell lines , 1991, FEBS letters.

[10]  N. Fausto.  Hepatocyte growth factor receptor and the c‐Met oncogene , 1991, Hepatology.

[11]  P. Comoglio,et al.  The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors , 1991, International journal of cancer.

[12]  W. Birchmeier,et al.  Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[14]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[15]  S. Hirono,et al.  Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme‐linked immunosorbent assay , 1991, Hepatology.

[16]  H. Tsubouchi,et al.  Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure. , 1990, Biochimica et biophysica acta.

[17]  J. Bruix,et al.  Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. , 1990, Journal of hepatology.

[18]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[19]  G. Michalopoulos,et al.  Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. , 1989, Cancer research.

[20]  P. Comoglio,et al.  p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line , 1988, Molecular and cellular biology.

[21]  S. Hirono,et al.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. , 1988, The Journal of clinical investigation.

[22]  Toshikazu Nakamura,et al.  Purification and subunit structure of hepatocyte growth factor from rat platelets , 1987, FEBS letters.

[23]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.

[24]  P. Johnson,et al.  Cirrhosis and the aetiology of hepatocellular carcinoma. , 1987, Journal of hepatology.

[25]  C. Cooper,et al.  Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. , 1986, The EMBO journal.

[26]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[27]  T. Nakamura,et al.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.

[28]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.